Pharmaceutical Pomalidomide Raw Powder Pomalidomide Purity Pomalidomide
Product Description
Product Details
Product Name |
Pomalidomide |
CAS NO. |
19171-19-8 |
Purity |
99% |
Density |
1.57 |
Appearance and shape |
Yellow powder |
Pomalidomide is an orally bioavailable derivative of thalidomide with potential immunomodulating, antiangiogenic and antineoplastic activities. Although its exact mechanism of action has yet to be fully elucidated, pomalidomide appears to inhibit TNF-alpha production, enhance the activity of T cells and natural killer (NK) cells and enhance antibody-dependent cellular cytotoxicity (ADCC). In addition, pomalidomide may inhibit tumor angiogenesis, promote cell cycle arrest in susceptible tumor cell populations, and stimulate erythropoeisis.
Application&Function
Pomalidomide is indicated for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.
Specification